What is the feasibility of switching to 200IU OnabotulinumtoxinA in patients with detrusor overactivity who have previously received 300IU?
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Christopher R Chapple |
| Publication date | April 17, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |